Oryzon Genomics (LTS:0RDB) Accounts Payable & Accrued Expense : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Oryzon Genomics Accounts Payable & Accrued Expense?

Oryzon Genomics's quarterly accounts payable & accrued expense increased from Mar. 2024 (€0.00 Mil) to Jun. 2024 (€2.62 Mil) but then declined from Jun. 2024 (€2.62 Mil) to Sep. 2024 (€0.00 Mil).

Oryzon Genomics's annual accounts payable & accrued expense increased from Dec. 2021 (€3.12 Mil) to Dec. 2022 (€5.27 Mil) but then declined from Dec. 2022 (€5.27 Mil) to Dec. 2023 (€3.62 Mil).

Oryzon Genomics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oryzon Genomics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Accounts Payable & Accrued Expense Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.46

2.22

3.12

5.27

3.62

Oryzon Genomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.17	3.62	-	2.62	-

Oryzon Genomics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oryzon Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (LTS:0RDB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ORY:Spain ORN:Germany

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.

Oryzon Genomics Headlines

No Headlines